Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5986 to 6000 of 7682 results

  1. At what gestation should treatment with prophylactic vaginal progesterone for the prevention of preterm birth be started and stopped?

    Recommendation ID NG25/7 Question At what gestation should treatment with prophylactic vaginal progesterone for the prevention of preterm

    Research recommendation
    Published
    25 October 2019

  2. Does progesterone reduce the risk of preterm birth in women who have a short cervix (cervical length of 25 mm or less), but do not have other risk factors for preterm birth?

    Recommendation ID NG25/6 Question Does progesterone reduce the risk of preterm birth in women who have a short cervix (cervical length

    Research recommendation
    Published
    25 October 2019

  3. Does progesterone reduce the risk of preterm birth in women who have risk factors for preterm birth, but do not have a short cervix (cervical length of more than 25 mm)?

    Recommendation ID NG25/5 Question Does progesterone reduce the risk of preterm birth in women who have risk factors for preterm birth,

    Research recommendation
    Published
    25 October 2019

  4. Given the limited evidence available, the original guidance committee noted that it would be beneficial to routinely collect data on all ureteric stent placement procedures. This was ideally in collaboration with a national professional society such as the British Association of Urological Surgeons. Clinical experts confirmed that an NHS registry for stent procedures has not been set up since the original guidance, and the evidence base remains limited with no prospective data available. The committee for this guidance update considered it important to further emphasise the need for collecting data using a national database or clinical registry on ureteric stent procedures. The prospective data collection should cover information about patient selection, choice of stent placement procedure and stent used, and adverse events such asstent migration and encrustation rates. It concluded that this should form part of its recommendations in section 1 of the guidance, and agreed that such data collection should be used to help inform the most appropriate patient population for Memokath 051.

    Recommendation ID MTG75/01 Question Given the limited evidence available, the original guidance committee noted that it would be beneficial

    Research recommendation
    Published
    6 January 2023

  5. Psychosocial interventions for people with more severe learning disabilities:- For people with more severe learning disabilities, what is the clinical and cost effectiveness of psychosocial interventions to treat mental health problems?

    Recommendation ID NG54/5 Question Psychosocial interventions for people with more severe learning disabilities:- For people with more severe

    Research recommendation
    Published
    17 October 2016

  6. Psychotic symptoms (hallucinations and delusions):- What is the effectiveness of rivastigmine compared with atypical antipsychotic drugs for treating psychotic symptoms (particularly hallucinations and delusions) associated with Parkinson's disease?

    Recommendation ID NG71/3 Question Psychotic symptoms (hallucinations and delusions):- What is the effectiveness of rivastigmine compared

    Research recommendation
    Published
    15 October 2018

  7. Psychological assessment:- What is the most effective measure of psychological functioning to use as a test for thresholds of concern in people with cystic fibrosis?

    Recommendation ID NG78/4 Question Psychological assessment:- What is the most effective measure of psychological functioning to use as

    Research recommendation
    Published
    18 October 2018

  8. Psychological interventions:- Are the psychological interventions [cognitive behavioural therapy] (CBT), hypnotherapy and psychological therapy all equally effective in the management of [Irritable bowel syndrome] (IBS) symptoms, either as first-line therapies in primary care, or in the treatment of people with IBS that is refractory to other treatments?

    Recommendation ID CG61/2 Question Psychological interventions:- Are the psychological interventions [cognitive behavioural therapy] (CBT)

    Research recommendation
    Published
    9 June 2015

  9. Pulmonary rehabilitation during hospital admission:- In people with COPD, does pulmonary rehabilitation during hospital admission for exacerbation and/or in the early recovery period (within 1 month of an exacerbation) improve quality of life and reduce hospitalisations and exacerbations compared with a later (defined as after 1 month)pulmonary rehabilitation programme, and in which groups is it most clinically and cost effective?

    Recommendation ID NG115/1 Question Pulmonary rehabilitation during hospital admission:- In people with COPD, does pulmonary rehabilitation

    Research recommendation
    Published
    6 February 2019

  10. Psychological interventions for children and young people with internalising disorders:- For children and young people with learning disabilities, what psychological interventions (such as cognitive behavioural therapy and interpersonal therapy) are clinically and cost effective for treating internalising disorders?

    Recommendation ID NG54/2 Question Psychological interventions for children and young people with internalising disorders:- For children

    Research recommendation
    Published
    17 October 2016

  11. Psychological interventions for depression and anxiety disorders in adults with mild to moderate learning disabilities:- For adults with milder learning disabilities, what is the clinical and cost effectiveness of psychological interventions such as cognitive behavioural therapy (modified for people with learning disabilities) for treating depression and anxiety disorders?

    Recommendation ID NG54/3 Question Psychological interventions for depression and anxiety disorders in adults with mild to moderate learning

    Research recommendation
    Published
    17 October 2016

  12. Pulmonary rehabilitation to improve outcomes in people with idiopathic pulmonary fibrosis:- Does pulmonary rehabilitation improve outcomes for people with idiopathic pulmonary fibrosis?

    Recommendation ID CG163/3 Question Pulmonary rehabilitation to improve outcomes in people with idiopathic pulmonary fibrosis:- Does pulmonary

    Research recommendation
    Published
    9 June 2015

  13. NICE encourages further research into the role of negative pressure wound therapy (NPWT) for the open abdomen. Patient selection should be documented and research should report on efficacy outcomes such as impact on wound care and healing rates, and duration of hospital stay.

    Recommendation ID IPG467/1 Question NICE encourages further research into the role of negative pressure wound therapy (NPWT) for the open

    Research recommendation
    Published
    9 June 2015

  14. NICE encourages further research into the use of a wireless capsule to assess motility of the gastrointestinal tract. Studies should include clear details of patient selection. They should report on the diagnostic accuracy of the procedure in different parts of the gastrointestinal tract, and should provide data on the clinical benefits of the procedure for patients.

    Recommendation ID IPG502/1 Question NICE encourages further research into the use of a wireless capsule to assess motility of the gastrointestinal

    Research recommendation
    Published
    9 June 2015

  15. NICE encourages further research on sphenopalatine ganglion stimulation for chronic cluster headache. Reported outcomes should include long-term efficacy and device durability.

    Recommendation ID IPG527/1 Question NICE encourages further research on sphenopalatine ganglion stimulation for chronic cluster headache

    Research recommendation
    Published
    6 October 2015